Antiviral Drug Favipiravir is a broad-spectrum inhibitor of viral RNA polymerase, an enzyme required for viral replication when human host cells are infected. Favipiravir is effective in preventing viral transcription and replication of RNA polymerase. It is also used to treat Influenza and it has been investigated in other countries to treat novel viruses including Ebola and recently, COVID-19.
As per the sources, the Chinese health and technology ministry announced that the Favipiravir drug had been effective in treating Coronavirus in 340 patients. In one of the trials, 35 patients who received the drug cleared the virus in four days, whereas a control group of 45 patients in the same facility who did not receive the drug took 11 days to clear the virus.
Favipiravir Tablet is used in the treatment of Influenza and Ebola, also been investigated for treatment of Coronavirus
* To be consumed as directed by physician.